Leflunomide has incremental cost advantage in RA

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 318, 2001 , pp. 7-7(1)

Publisher: Adis International

Keywords: Cost-minimisation; Infliximab, therapeutic use; Leflunomide, therapeutic use; Methotrexate, therapeutic use; Rheumatoid-arthritis, treatment

Language: English

Document Type: Research article

Publication date: 2001-01-01

• In this: publication
• By this: publisher
• In this Subject: Pharmacology

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers